Sponsor:
Johnson & Johnson Enterprise Innovation Inc.
Code:
NCT04892173
Conditions
Locally Advanced Head and Neck Squamous Cell Carcinoma
Aged
Eligibility Criteria
Sex: All
Age: 60+
Healthy Volunteers: Not accepted
Interventions
JNJ-90301900 (NBTXR3)
Cetuximab
Radiation Therapy
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations